I would like to receive updates and special offers from Dow Jones and affiliates. I can unsubscribe at any time.
Tyra Biosciences and Johnson & Johnson are pursuing their own approaches to treating a common, early-stage form of bladder cancer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results